FDA Recalls Glimepiride Tablets for Manufacturing Deviations
Northwind Pharmaceuticals is voluntarily recalling Glimepiride 2mg tablets distributed nationwide due to Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
- Product
- GLIMEPIRIDE — GLIMEPIRIDE (GLIMEPIRIDE)
- Category
- Drug
- Distribution
- Distributed nationwide